Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| EASTMAN CHEMICAL COEMN · Entity 1780 | Senior Vice President | February 15, 2019 | February 19, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
EASTMAN CHEMICAL CO
Report date February 15, 2019 · Filed February 19, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,856 |
Ending reported balance
After 2019-02-15 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2019-02-15 · Grant · Acquired 2,485 · Balance 2,485 F1: Payout under performance shares awarded at beginning of three-year (2016-2018) performance period. Row 2 · 2019-02-15 · Tax withholding · Disposed 629 · Balance 1,856 F2: Shares of common stock withheld in payment of tax liability incident to payout under performance shares. |
Filing footnotes · ownership attribution and instrument terms
F1: Payout under performance shares awarded at beginning of three-year (2016-2018) performance period.
F2: Shares of common stock withheld in payment of tax liability incident to payout under performance shares.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 15, 2019 Filed Feb 19, 2019 19:52 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | Tax withholdingCommon Stock | 629 | $82.71 | $52,024.59 |
DisclosureSEC source: 0000899243-19-004025 · doc4.xml · nonDerivative · entry 2 WARMACK DAMON CARY · CIK 0001678132 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,856 F2 · shares: Shares of common stock withheld in payment of tax liability incident to payout under performance shares. Read SEC document |
| February 15, 2019 Filed Feb 19, 2019 19:52 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | GrantCommon Stock | 2,485 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-004025 · doc4.xml · nonDerivative · entry 1 WARMACK DAMON CARY · CIK 0001678132 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,485 F1 · shares: Payout under performance shares awarded at beginning of three-year (2016-2018) performance period. Read SEC document |
| February 26, 2018 Filed Feb 27, 2018 20:32 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | GrantEmployee Stock Option (right to buy) · Derivative | 20,216 | $0.00 Strike: $104.21 | $0.00 |
DisclosureSEC source: 0000899243-18-005609 · doc4.xml · derivative · entry 2 WARMACK DAMON CARY · CIK 0001678132 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,216 Underlying: Common Stock · 20,216 shares Expires 2028-02-25 F2 · derivative.exercise_date: One-third of the option becomes exercisable on February 26, 2019, February 26, 2020, and February 26, 2021, respectively. Read SEC document |
| February 23, 2018 Filed Feb 27, 2018 20:32 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | SaleCommon Stock | 2,710 | $102.22 | $277,016.20 |
DisclosureSEC source: 0000899243-18-005609 · doc4.xml · nonDerivative · entry 1 WARMACK DAMON CARY · CIK 0001678132 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person and his broker on December 4, 2017. Read SEC document |
| February 16, 2018 Filed Feb 20, 2018 13:51 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | Tax withholdingCommon Stock | 903 | $100.13 | $90,417.39 |
DisclosureSEC source: 0000899243-18-004502 · doc4.xml · nonDerivative · entry 2 WARMACK DAMON CARY · CIK 0001678132 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,710 F2 · shares: Shares of common stock withheld in payment of tax liability incident to payout under performance shares. Read SEC document |
| February 16, 2018 Filed Feb 20, 2018 13:51 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | GrantCommon Stock | 3,613 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-004502 · doc4.xml · nonDerivative · entry 1 WARMACK DAMON CARY · CIK 0001678132 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,613 F1 · shares: Payout under performance shares awarded at beginning of three-year (2015-2017) performance period. Read SEC document |
| February 07, 2018 Filed Feb 9, 2018 13:38 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | SaleCommon Stock | 4,417 | $98.60 | $435,516.20 |
DisclosureSEC source: 0000899243-18-003345 · doc4.xml · nonDerivative · entry 1 WARMACK DAMON CARY · CIK 0001678132 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person and his broker December 4, 2017. Read SEC document |
| October 20, 2017 Filed Oct 23, 2017 17:09 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | Exercise / conversionRestructed Stock Units · Derivative | 1,758 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-17-024548 · doc4.xml · derivative · entry 3 WARMACK DAMON CARY · CIK 0001678132 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,758 shares Expires 2017-10-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Payout of shares underlying restricted stock units upon satisfaction of time condition to vesting. F1 · price: Payout of shares underlying restricted stock units upon satisfaction of time condition to vesting. F1 · derivative.exercise_date: Payout of shares underlying restricted stock units upon satisfaction of time condition to vesting. Read SEC document |
| October 20, 2017 Filed Oct 23, 2017 17:09 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | Tax withholdingCommon Stock | 481 | $88.82 | $42,722.42 |
DisclosureSEC source: 0000899243-17-024548 · doc4.xml · nonDerivative · entry 2 WARMACK DAMON CARY · CIK 0001678132 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,417 F2 · shares: Shares of common stock withheld in satisfaction of tax liability upon vesting of the 1,758 restricted stock units. Read SEC document |
| October 20, 2017 Filed Oct 23, 2017 17:09 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | Exercise / conversionCommon Stock | 1,758 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-17-024548 · doc4.xml · nonDerivative · entry 1 WARMACK DAMON CARY · CIK 0001678132 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,898 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Payout of shares underlying restricted stock units upon satisfaction of time condition to vesting. Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 14:10 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | GrantEmployee Stock Option (right to buy) · Derivative | 17,227 | $0.00 Strike: $80.25 | $0.00 |
DisclosureSEC source: 0000899243-17-005920 · doc4.xml · derivative · entry 1 WARMACK DAMON CARY · CIK 0001678132 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,227 Underlying: Common Stock · 17,227 shares Expires 2027-02-27 F1 · derivative.exercise_date: One-third of the option becomes exercisable on February 28, 2018, February 28, 2019, and February 28, 2020, respectively. Read SEC document |
| February 17, 2017 Filed Feb 21, 2017 13:42 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | Tax withholdingCommon Stock | 276 | $80.25 | $22,149.00 |
DisclosureSEC source: 0000899243-17-004657 · doc4.xml · nonDerivative · entry 2 WARMACK DAMON CARY · CIK 0001678132 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,140 F2 · shares: Shares of common stock withheld in payment of tax liability incident to payout under performance shares. Read SEC document |
| February 17, 2017 Filed Feb 21, 2017 13:42 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | GrantCommon Stock | 864 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-17-004657 · doc4.xml · nonDerivative · entry 1 WARMACK DAMON CARY · CIK 0001678132 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,416 F1 · shares: Payout under performance shares awarded at beginning of three-year (2014-2016) performance period. Read SEC document |
| October 20, 2016 Filed Oct 24, 2016 14:01 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | Exercise / conversionRestricted Stock Units · Derivative | 3,513 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-16-032207 · doc4.xml · derivative · entry 3 WARMACK DAMON CARY · CIK 0001678132 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,758 Underlying: Common Stock · 3,513 shares Expires 2016-10-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Payout of shares underlying restricted stock units upon satisfaction of time condition to vesting. F1 · price: Payout of shares underlying restricted stock units upon satisfaction of time condition to vesting. F1 · derivative.exercise_date: Payout of shares underlying restricted stock units upon satisfaction of time condition to vesting. F3 · balance_after: Remaining one-third of the underlying shares that vest on 10/20/2017 subject to continued employment. Read SEC document |
| October 20, 2016 Filed Oct 24, 2016 14:01 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | Tax withholdingCommon Stock | 961 | $66.89 | $64,281.29 |
DisclosureSEC source: 0000899243-16-032207 · doc4.xml · nonDerivative · entry 2 WARMACK DAMON CARY · CIK 0001678132 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,552 F2 · shares: Shares of common stock withheld in satisfacton of tax liability upon vesting of the 3,513 restricted stock units. Read SEC document |
| October 20, 2016 Filed Oct 24, 2016 14:01 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | Exercise / conversionCommon Stock | 3,513 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-16-032207 · doc4.xml · nonDerivative · entry 1 WARMACK DAMON CARY · CIK 0001678132 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,513 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Payout of shares underlying restricted stock units upon satisfaction of time condition to vesting. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.